Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

AAV vectors for RNA-based modulation of gene expression

Gene Therapy volume 15, pages 864–869 (2008)Cite this article

Abstract

At the post-transcriptional level, gene expression is largely regulated through a network of molecular machines that regulate pre-mRNA maturation integrity, transport, translation and degradation. These processes are based on the formation of nucleoprotein complexes and require the recognition of sequence motifs on the RNA. By masking these targets with complementary RNA sequences forming Watson–Crick base pairing, it is possible to efficiently and specifically impact on the cell phenotype, or to compensate the deleterious effect of mutations. Here we review how the adeno-associated virus technology is being exploited for expressing non-coding RNAs in tissues such as the brain, muscle or liver, in functional genomic studies as well as for the development of novel therapeutic strategies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Conrad SE, Campbell JL . Role of plasmid-coded RNA and ribonuclease III in plasmid DNA replication. Cell 1979; 18: 61–71.

    Article  CAS  PubMed  Google Scholar 

  2. Izant JG, Weintraub H . Inhibition of thymidine kinase gene expression by anti-sense RNA: a molecular approach to genetic analysis. Cell 1984; 36: 1007–1015.

    Article  CAS  PubMed  Google Scholar 

  3. Kumar M, Carmichael GG . Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. Proc Natl Acad Sci USA 1997; 94: 3542–3547.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. McManus MT, Sharp PA . Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002; 3: 737–747.

    Article  CAS  PubMed  Google Scholar 

  5. Lewin AS, Hauswirth WW . Ribozyme gene therapy: applications for molecular medicine. Trends Mol Med 2001; 7: 221.

    Article  CAS  PubMed  Google Scholar 

  6. Tazi J, Durand S, Jeanteur P . The spliceosome: a novel multi-faceted target for therapy. Trends Biochem Sci 2005; 30: 469–478.

    Article  CAS  PubMed  Google Scholar 

  7. Sullenger BA, Cech TR . Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature 1994; 371: 619.

    Article  CAS  PubMed  Google Scholar 

  8. Puttaraju M, Jamison SF, Mansfield SG, Garcia-Blanco MA, Mitchell LG . Spliceosome-mediated RNA trans-splicing as a tool for gene therapy. Nat Biotechnol 1999; 17: 246–252.

    Article  CAS  PubMed  Google Scholar 

  9. Kim DH, Rossi JJ . Strategies for silencing human disease using RNA interference. Nat Rev Genet 2007; 8: 173–184.

    Article  CAS  PubMed  Google Scholar 

  10. Auricchio A, Kobinger G, Anand V, Hildinger M, O′Connor E, Maguire AM et al. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum Mol Genet 2001; 10: 3075–3081.

    Article  CAS  PubMed  Google Scholar 

  11. Nakai H, Yant SR, Storm TA, Fuess S, Meuse L, Kay MA . Extrachromosomal recombinant adeno-associatedvirus vector genomes are primarily responsible for stable liver transduction in vivo. J Virol 2001; 75: 6969–6976.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Chang K, Elledge SJ, Hannon GJ . Lessons from Nature: microRNA-based shRNA libraries. Nat Methods 2006; 3: 707.

    Article  CAS  PubMed  Google Scholar 

  13. Poluri A, Sutton RE . Titers of HIV-based vectors encoding shRNAs are reduced by a dicer-dependent mechanism. Mol Ther 2007; 16: 378–386.

    Article  PubMed  Google Scholar 

  14. Fritz JJ, Lewin A, Hauswirth W, Agarwal A, Grant M, Shaw L . Development of hammerhead ribozymes to modulate endogenous gene expression for functional studies. Methods 2002; 28: 276–285.

    Article  CAS  PubMed  Google Scholar 

  15. Gorman L, Suter D, Emerick V, Schumperli D, Kole R . Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs. Proc Natl Acad Sci USA 1998; 95: 4929–4934.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Denti MA, Rosa A, D′Antona G, Sthandier O, Angelis FGD, Nicoletti C et al. Chimeric adeno-associated virus/antisense U1 small nuclear RNA effectively rescues dystrophin synthesis and muscle function by local treatment of mdx mice. Hum Gene Ther 2006; 17: 565–574.

    Article  CAS  PubMed  Google Scholar 

  17. Millington-Ward S, O′Neill B, Tuohy G, Al-Jandal N, Kiang AS, Kenna PF et al. Strategems in vitro for gene therapies directed to dominant mutations. Hum Mol Genet 1997; 6: 1415–1426.

    Article  CAS  PubMed  Google Scholar 

  18. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006; 441: 537.

    Article  CAS  PubMed  Google Scholar 

  19. Rendahl KG, Leff SE, Otten GR, Spratt SK, Bohl D, Van Roey M et al. Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol 1998; 16: 757–761.

    Article  CAS  PubMed  Google Scholar 

  20. Henriksen JR, Lokke C, Hammero M, Geerts D, Versteeg R, Flaegstad T et al. Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell lines. Nucleic Acids Res 2007; 35: e67.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Bontempi B, Laurent-Demir C, Destrade C, Jaffard R . Time-dependent reorganization of brain circuitry underlying long-term memory storage. Nature 1999; 400: 671.

    Article  CAS  PubMed  Google Scholar 

  22. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 2004; 10: 302–317.

    Article  CAS  PubMed  Google Scholar 

  23. Kaemmerer WF, Reddy RG, Warlick CA, Hartung SD, McIvor RS, Low WC . In vivo transduction of cerebellar Purkinje cells using adeno-associated virus vectors. Mol Ther 2000; 2: 446–457.

    Article  CAS  PubMed  Google Scholar 

  24. Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet 2004; 36: 827–835.

    Article  CAS  PubMed  Google Scholar 

  25. Babcock AM, Standing D, Bullshields K, Schwartz E, Paden CM, Poulsen DJ . In vivo inhibition of hippocampal Ca2+/calmodulin-dependent protein kinase II by RNA interference. Mol Ther 2005; 11: 899.

    Article  CAS  PubMed  Google Scholar 

  26. Xia H, Mao Q, Eliason SL, Harper SQ, Martins IH, Orr HT et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 2004; 10: 816.

    Article  CAS  PubMed  Google Scholar 

  27. Harper SQ, Staber PD, He X, Eliason SL, Martins IH, Mao Q et al. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc Natl Acad Sci USA 2005; 102: 5820–5825.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Machida Y, Okada T, Kurosawa M, Oyama F, Ozawa K, Nukina N . rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse. Biochem Biophys Res Commun 2006; 343: 190.

    Article  CAS  PubMed  Google Scholar 

  29. Rodriguez-Lebron E, Denovan-Wright EM, Nash K, Lewin AS, Mandel RJ . Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice. Mol Ther 2005; 12: 618.

    Article  CAS  PubMed  Google Scholar 

  30. Hommel JD, Sears RM, Georgescu D, Simmons DL, DiLeone RJ . Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med 2003; 9: 1539.

    Article  CAS  PubMed  Google Scholar 

  31. Hayashita-Kinoh H, Yamada M, Yokota T, Mizuno Y, Mochizuki H . Down-regulation of [alpha]-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model. Biochem Biophys Res Commun 2006; 341: 1088.

    Article  CAS  PubMed  Google Scholar 

  32. Haberman R, Criswell H, Snowdy S, Ming Z, Breese G, Samulski R et al. Therapeutic liabilities of in vivo viral vector tropism: adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity. Mol Ther 2002; 6: 495–500.

    Article  CAS  PubMed  Google Scholar 

  33. LaVail MM, Yasumura D, Matthes MT, Drenser KA, Flannery JG, Lewin AS et al. Ribozyme rescue of photoreceptor cells in P23 H transgenic rats: Long-term survival and late-stage therapy. Proc Natl Acad Sci USA 2000; 97: 11488–11493.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Lewin AS, Drenser KA, Hauswirth WW, Nishikawa S, Yasumura D, Flannery JG et al. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat Med 1998; 4: 967–971.

    Article  CAS  PubMed  Google Scholar 

  35. Gorbatyuk M, Justilien V, Liu J, Hauswirth WW, Lewin AS . Preservation of photoreceptor morphology and function in P23 H rats using an allele independent ribozyme. Exp Eye Res 2007; 84: 44.

    Article  CAS  PubMed  Google Scholar 

  36. Tessitore A, Parisi F, Denti MA, Allocca M, Di Vicino U, Domenici L et al. Preferential silencing of a common dominant rhodopsin mutation does not inhibit retinal degeneration in a transgenic model. Mol Ther 2006; 14: 692.

    Article  CAS  PubMed  Google Scholar 

  37. O′Reilly M, Palfi A, Chadderton N, Millington-Ward S, Ader M, Cronin T et al. RNA interference-mediated suppression and replacement of human rhodopsin in vivo. Am J Hum Genet 2007; 81: 127–135.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Aarnisalo AA, Pietola L, Joensuu J, Isosomppi J, Aarnisalo P, Dinculescu A et al. Anti-clarin-1 AAV-delivered ribozyme induced apoptosis in the mouse cochlea. Hear Res 2007; 230: 9.

    Article  CAS  PubMed  Google Scholar 

  39. Liu J, Timmers AM, Lewin AS, Hauswirth WW . Ribozyme knockdown of the {gamma}-subunit of rod cGMP phosphodiesterase alters the ERG and retinal morphology in wild-type mice. Invest Ophthalmol Vis Sci 2005; 46: 3836–3844.

    Article  PubMed  Google Scholar 

  40. Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J . Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis. Invest Ophthalmol Vis Sci 2007; 48: 681–691.

    Article  PubMed  Google Scholar 

  41. Justilien V, Pang J-J, Renganathan K, Zhan X, Crabb JW, Kim SR et al. SOD2 knockdown mouse model of early AMD. Invest Ophthalmol Vis Sci 2007; 48: 4407–4420.

    Article  PubMed  Google Scholar 

  42. Paskowitz DM, Greenberg KP, Yasumura D, Grimm D, Yang H, Duncan JL et al. Rapid and stable knockdown of an endogenous gene in retinal pigment epithelium. Hum Gene Ther 2007; 18: 871–880.

    Article  CAS  PubMed  Google Scholar 

  43. Andino LM, Takeda M, Kasahara H, Jakymiw A, Byrne BJ, Lewin AS . AAV-mediated knockdown of phospholamban leads to improved contractility and calcium handling in cardiomyocytes. J Gene Med 2008; 10: 132–142.

    Article  CAS  PubMed  Google Scholar 

  44. Magee TR, Artaza JG, Ferrini MG, Vernet D, Zuniga FI, Cantini L et al. Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass. J Gene Med 2006; 8: 1171–1181.

    Article  CAS  PubMed  Google Scholar 

  45. Goyenvalle A, Vulin A, Fougerousse F, Leturcq F, Kaplan JC, Garcia L et al. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 2004; 306: 1796–1799.

    Article  CAS  PubMed  Google Scholar 

  46. t Hoen PA, van der Wees CG, Aartsma-Rus A, Turk R, Goyenvalle A, Danos O et al. Gene expression profiling to monitor therapeutic and adverse effects of antisense therapies for Duchenne muscular dystrophy. Pharmacogenomics 2006; 7: 281–297.

    Article  CAS  Google Scholar 

  47. Denti MA, Rosa A, D′Antona G, Sthandier O, De Angelis FG, Nicoletti C et al. Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model. Proc Natl Acad Sci USA 2006; 103: 3758–3763.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. van Deutekom JC, Janson AA, Ginjaar IB, Frankhuizen WS, Aartsma-Rus A, Bremmer-Bout M et al. Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 2007; 357: 2677–2686.

    Article  CAS  PubMed  Google Scholar 

  49. Gardiner JV, Kong WM, Ward H, Murphy KG, Dhillo WS, Bloom SR . AAV mediated expression of anti-sense neuropeptide Y cRNA in the arcuate nucleus of rats results in decreased weight gain and food intake. Biochem Biophys Res Commun 2005; 327: 1088–1093.

    Article  CAS  PubMed  Google Scholar 

  50. Hommel JD, Trinko R, Sears RM, Georgescu D, Liu Z-W, Gao X-B et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 2006; 51: 801.

    Article  CAS  PubMed  Google Scholar 

  51. Kimura B, Mohuczy D, Tang X, Phillips MI . Attenuation of hypertension and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense. Hypertension 2001; 37: 376–380.

    Article  CAS  PubMed  Google Scholar 

  52. Wang X, Skelley L, Cade R, Sun Z . AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage. Gene Therapy 2006; 13: 1097–1103.

    Article  CAS  PubMed  Google Scholar 

  53. Sun Z, Roufai MB, Wang X . RNAi inhibition of mineralocorticoid receptors (MR) prevents the development of cold-induced hypertension. Am J Physiol Heart Circ Physiol 2008: (in press).

  54. Shenouda SM, Johns C, Gavras I, Gavras H . Long-term inhibition of the central [alpha]2B-adrenergic receptor gene via recombinant AAV-delivered antisense in hypertensive rats[ast]. Am J Hypertens 2006; 19: 1135–1143.

    Article  CAS  PubMed  Google Scholar 

  55. Liu X, Luo M, Zhang LN, Yan Z, Zak R, Ding W et al. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells. Hum Gene Ther 2005; 16: 1116–1123.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Inserm U781, Hôpital Necker-Enfants Malades & Université Paris Descartes, Paris, France

    O Danos

Authors
  1. O Danos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O Danos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Danos, O. AAV vectors for RNA-based modulation of gene expression. Gene Ther 15, 864–869 (2008). https://doi.org/10.1038/gt.2008.69

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2008.69

Keywords

This article is cited by

Search

Advanced search

Quick links